The role of generics in kidney transplant: Mycophenolate mofetil 500 versus mycophenolate: 2-year results

Experimental and Clinical Transplantation

Volumn 8, Issue 4, 2010, Pages 292-296

  Ben Abdallah, Taieb ^a   Ounissi, Mondher ^a   Cherif, Mejda ^a   Helal, Imed ^a   Karoui, Cyrine ^a   Mhibik, Sonia ^a   Bacha, Med Mongi ^a   Abderrahim, Ezzeddine ^a   Kheder, Adel ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Acute rejection; Survival

Indexed keywords

CREATININE; GENERIC DRUG; HLA ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; INFECTION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; LEUKOPENIA; MALE; MAXIMUM PLASMA CONCENTRATION; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SIDE EFFECT; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; CREATININE; DRUGS, GENERIC; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUNISIA;

EID: 78650550475     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Djamali A, Premasathian N, Pirsch JD. Outcomes in kidney transplantation. Semin Nephrol. 2003;23(3):306-316.
2. Kim SJ, Huh KH, Han DJ, Moon IS, Kim SJ, Kim YL, et al. A 6- month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation. Transplant Proc. 2009;41(5):1671-1674.
3. Grinyo JM, Gil-Vernet S, Serón D, Cruzado JM, Moreso F, Fulladosa X, et al. Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients. Transplantation. 1997;63(11):1688-1690.
4. Stephan A, Barbari A, Kamel G, Aoun S, Masri MA. A one-center experience with a short course of mycophenolic acid. Transplant Proc. 1999;31(8):3289-3290.
5. Masri MA, Rizk S, Attia ML, Barbouch H, Rost M. Bioavailability of a new generic formulation of mycophenolate mofetil MMF 500 versus CellCept in healthy adult volunteers. Transplant Proc. 2007;39(4):1233-1236.
6. Meyer GF. History and regulatory issues of generic drugs. Transplant Proc. 1999;31(suppl 3A):10S-12S.
7. Masri MA, Haberal M, Rizvi A, Stephan A, Bilgin N, Naqvi A, et al. Switchability of neoral and equoral according to Food and Drug Administration rules and regulations. Transplant Proc. 2005;37(7):2988-2993.
8. Masri M. The generics in transplantation and the rules on their use. Exp Clin Transplant. 2003;1(1):65-68.
9. Müller H, Solari S, Zuñiga C, Pedreros C, Troncoso J, Morente C, et al. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. Transplant Proc. 2008;40(3):705-707.
10. Videla C, Godoy C. Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome. Transplant Proc. 2007;39(3):602-605.
11. [No authors listed]. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet. 1995;345(8961):1321-1325.
12. Houde I, Isenring P, Boucher D, Noël R, Lachanche JG. Mycophenolate mofetil, an alternative to cyclosporine A for longterm immunosuppression in kidney transplantation? Transplantation. 2000;70(8):1251-1253.
13. Hall B, Surany M. Handbook of Transplant Immunology. New York; Medsci Publications; 1995:13.
14. Stephan AG, Barbari A, Masri M, Kamel G, Barakat Khoury W, Karam A, et al. A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients. Transplant Proc. 1998;30(7):3563-3564.
15. Masri MA, Andrysek T, Rizk S, Matha V. The role of generics in transplantation: TM-MMF versus Cellcept in healthy volunteers. Transplant Proc. 2004;36(1):84-85.